Registry and benchmarking as tool for Quality assessment in STEMI patients

Similar documents
STEMI Management in Belgium

STEMI Management in Belgium

Quality assessment in STEMI patients: the Belgian STEMI registry :

Mode of admission and its effect on quality indicators in Belgian STEMI patients

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach

Pharmaco-Invasive Approach for STEMI

Management of Acute Myocardial Infarction

Patient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough

DISCUSSION QUESTION - 1

DECLARATION OF CONFLICT OF INTEREST

Continuing Medical Education Post-Test

ORIGINAL INVESTIGATION

Myocardial Infarction In Dr.Yahya Kiwan

Trends in reperfusion therapy of STEMI patients in Belgium for the period

STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION. STREAM 1Y AHA 2013 P Sinnaeve

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Frans Van de Werf, MD, PhD Leuven, Belgium

Management of Cardiogenic shock. Prof. Christian JM Vrints

Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients?

Approach to Multi Vessel disease with STEMI

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

4. Which survey program does your facility use to get your program designated by the state?

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium

Quality assessment in Belgian ST elevation myocardial infarction patients: results from the Belgian STEMI database

Transfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem

Downloaded from:

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Daily practice of ACS management in the Gulf: Data from Gulf COAST

Acute Coronary Syndrome

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

2018 Acute Coronary Syndrome. Robert Bender, DO, FACOI, FACC Central Maine Heart and Vascular Institute

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

STEMI and Cardiogenic Shock. The rules and solution. Dave Kettles St Dominics and Frere Hospitals East London ZA

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

ST-elevation myocardial infarctions (STEMIs)

Acute Coronary Syndromes

Pre Hospital and Initial Management of Acute Coronary Syndrome

SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI?

PHARMACO-INVASIVE STRATEGY COMPARED WITH PPCI: DESIGN AND MAIN OUTCOMES OF THE STREAM TRIAL

Impact of in-hospital delay to invasive treatment of NSTEMI patients on early and 12-month clinical outcomes

The Strategic Reperfusion Early After STEMI study Implications for clinical practice

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

STEMI 2014 YAHYA KIWAN. Consultant Cardiologist Head Of Cardiology Belhoul Specialty Hospital

Andreas Baumbach Bristol Heart Institute Bristol Royal Infirmary. London 27/1/2005

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention

STEMI Presentation and Case Discussion. Case #1

Learning Objectives. Epidemiology of Acute Coronary Syndrome

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

This House believes that experience and size is not relevant

Alex versus Xience Registry Preliminary report

Appendix: ACC/AHA and ESC practice guidelines

Acute Coronary Syndrome

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium

Ventricular Arrhythmias in Acute MI Patients Undergoing Primary PCI

FEMALE GENDER IN ACUTE CARDIAC CARE

Thrombolysis in Acute Myocardial Infarction

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options?

1 a) Please confirm or deny whether your Trust has admitted patients for acute myocardial infarction in 2008/09, 2009/10 or 2010/11

Randomized Comparison of Prasugrel and Bivalirudin versus Clopidogrel and Heparin in Patients with ST-Segment Elevation Myocardial Infarction

The PAIN Pathway for the Management of Acute Coronary Syndrome

Acute coronary syndromes

'Coronary artery bypass grafting in patients with acute coronary syndromes: perioperative strategies to improve outcome'

County of Santa Clara Emergency Medical Services System

ST Elevated Myocardial Infarction- Latest AHA recommendations

Ischemic Heart Disease Interventional Treatment

Updated and Guideline Based Treatment of Patients with STEMI

A Report From the Second National Registry of Myocardial Infarction (NRMI-2)

Early discharge in selected patients after an acute coronary syndrome can it be safe?

Ischemic Heart Disease Interventional Treatment

What is new in the Treatment of STEMI? Malcolm R. Bell, MBBS Mayo Clinic Rochester, MN

Otamixaban for non-st-segment elevation acute coronary syndrome

EXAMINATION trial. Manel Sabaté Hospital Clínic, Barcelona (On behalf of the Examination Investigators)

Prise en charge du SCA ST + en urgence. 9803mo01, 1

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction

Case Report Primary Percutaneous Coronary Intervention in an Acute Myocardial Infarction Due to the Occlusion of the Left Main Coronary Artery

Cindy L. Grines MD FACC FSCAI

2010 ACLS Guidelines. Primary goals of therapy for patients

ORIGINAL ARTICLE. Rescue PCI Versus a Conservative Approach for Failed Fibrinolysis in Patients with STEMI

The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network:

Critical Review Form Therapy Objectives: Methods:

PPCI in STEMI. ESC at the 22nd Annual Conference of the Saudi Heart Association February 21th, 2011

THE INCIDENCE OF PECTORIS ANGINA POST-ACUTE MYOCARDIAL INFARCTION IN ROMANIA RO-STEMI DATABASE

A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD

BWGIC Activity report 2014

Thrombolysis, adjunctive pharmacology and interventions

Antithrombotic Therapy in ACS Pretreatment in STEMI. Christian W. Hamm Kerckhoff Heart & Thorax Center Bad Nauheim Germany

APPENDIX F: CASE REPORT FORM

Subsequent management and therapies

Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy.

Recovering Hearts. Saving Lives.

Cardiac Rehabilitation after Primary Coronary Intervention CONTRA

SHOULD BETA BLOCKERS BE USED ROUTINELY IN POST MI PATIENTS WITH PRESERVED LV FUNCTION?

Thrombolysis in Cardiology to whom? Professor Steen D. Kristensen, MD, DMSc, FESC Department of Cardiology

Emergency surgery in acute coronary syndrome

The ESC Registry on Chronic Ischemic Coronary Disease

Update on the management of STEMI. Elliot Rapaport, M.D. San Francisco, CA December 14, 2007

Acute Coronary Syndrome. Sonny Achtchi, DO

Transcription:

Registry and benchmarking as tool for Quality assessment in STEMI patients Belgian Interdisciplinary Working Group on Acute Cardiology (BIWAC) College of Cardiology April 2007

Background Reperfusion strategy STEMI STEMI registration in Belgium Electronic CRF Analysis and report Practical organisation

AMI - Prognosis MEN WOMEN 28 d. Case Fatality 49% (35-60%) 51% (34-70%) WHO- MONICA 1985-1990 40 30 20 10 0 pre-hosp. hospital pre-hosp hospital

Case-Fatality in Ghent in men 25-69 years Case-Fatality Rate (%) 60 50 40 30 All Hospitalised cases 20 10 0 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 Year Prof. G. De Backer, Ghent

Lethality of AMI 2000-2003: MKG data N= 44782 AMI in hospital lethality: 15.9% From dr W Aelvoet, RIZIV/ENAMI

Lethality of AMI 2000-2003: MKG data % 35 30 25 20 15 10 5 0 AMI-letaliteit/Leeftijd en geslacht 18-39 40-64 65-79 80+ Mannen Vrouw en Leeftijdsgroep

What are the reasons of variation in lethality? Different patient risk profile? Shock age - ischemic time Correction with TIMI risk score Different reperfusion modalities? trombolysis vs PCI vs no reperfusion

Background Reperfusion strategy STEMI STEMI registration in Belgium Electronic CRF Analysis and report Practical organisation

Optimalisation of reperfusion therapy (ESC report) 1. Reperfusion therapy (thrombolysis PCI) in STEMI favourably influences short and long term patient outcome 2. Up to 40% of all STEMI patients do not receive reperfusion therapy in Europe (ESC-ACS registry 2001). (Belgian data?) 3. Optimalisation of reperfusion therapy can be achieved by organising conference meetings, providing guidelines and setting up registries. 4. Importance of networks of reperfusion (including transport organisation) to limit time delay between onset of symptoms and initiation of reperfusion therapy.

Time issue and reperfusion therapy 30 minutes delay increases 1-year mortality by 7.5% Meta-analysis primary PCI: De Luca, Circulation 2004

Time issue and reperfusion strategy If PCI-related time delay >60 min, the benefit of PCI over thrombolyis vanishes

ST elevation MI (<12 h after onset of pain) Aspirin heparin nitrate * Admission in PCI-center Admission in non-pci-center or first medical contact outside hospital Transfer ** PCI center YES Hemodynamic instability (shock / cardiac failure/ malignant arrythmias) contra-indication thrombolysis Transfer to PCI center NO OR Thrombolysis start clopidogrel Primary PCI ** First medical contact-to-balloon time < 90±30 min Consider IIB-IIIa antagonists Pro transfer: transfer time<60, ischemia >3u Pro thrombolysis: transfer time>60, ischemia<3u Failed *** Rescue PCI * nitrate SL unless systolic bloodpressure<100mmhg and/ or heart rate<50bpm ** Consider pre-pci lytic therapy if transfer time>60 min *** Electrocardiographic and clinical evaluation 60-90 min after initiation of thrombolysis

Background Reperfusion strategy STEMI STEMI registration in Belgium Electronic CRF Analysis and report Practical organisation

STEMI registry in Belgium: AIM Prospective registry of all ST elevation myocardial infarctions admitted in Belgian hospitals (critical care program A) Quality assessment of critical care by means of on-line reports allowing benchmarking. Evaluation of predictors of in hospital mortality for STEMI in Belgium

STEMI registry : Organisation Ministry of Public Health College of Cardiology BIWAC * Steering committee: 16 members regional representation Local Investigators: one (two) responsibles / hospital Belgian Interdisciplinary working group of acute cardiology

STEMI registry : Steering committee Antwerpen: M Claeys S Hellemans - C Convens Oost-Vlaanderen: H De Raedt - S Gevaert West Vlaanderen: P Coussement K Dujardin Limburg: P Vranckx - J Dens Vlaams Brabant: P Sinnaeve - Brussel: M Renard - B Faoding Hainaut: P Dubois A de Meester Liege: J Boland Namur Luxembourg: P Evrard - C Beauloye Braband -Wallon

STEMI registry : organisation Q1-2 2006: Pilot study ( one patient/centre) evaluation of content of CRF Q3-Q4 2006: installation of web-based registry Independent software company Lambda-plus (http://www.lambdaplus.com) Q1 2007: Application of registry by steering committee members enrollment 20/4: n= 300 STEMI patient Q2 2007: Implementation of registry in all Belgian hospitals organisation of regional starting-up meetings Q3 2007: Interim analysis Q4 2007: analysis and report 2007

Background Reperfusion strategy STEMI STEMI registration in Belgium Electronic CRF Analysis and report Practical organisation

Minimal Data Base Patient characteristics (TIMI risk score) Reperfusion strategy In Hospital Outcome Electronic CRF

Minimal Data Base Patient characteristics (TIMI risk score) Reperfusion strategy In Hospital Outcome Electronic CRF

Minimal Data Base Definition ST Elevation Myocardial Infarction: Clinical picture of acute myocardial infarction with significant ST-T elevation in at least two ECG leads (>0.1 mv in peripheral leads, >0.2mv in precordial leads) STEMI as an acute complication of a coronary intervention is excluded from the STEMI registry

Minimal Data Base HOSPITAL IDENTIFICATION: The first hospital where patient is admitted and where he stays for more than 24 hours Example: 1. STEMI patient admitted in hospital A transfer for PCI to hospital B and back discharge in hospital A > hospital A completes the e-crf 2. STEMI patient admitted in hospital A transfer for PCI in hospital B discharge (or death) in hospital B > hospital B completes the e-crf

Minimal Data Base PATIENT IDENTIFICATION: Informed consent (cf privacy law) example of document on the website No ethical documents needed Identification on the local CRF: free text (will not appear in the analysis)

Minimal Data Base CARDIOVASCULAR HISTORY Ischemic heart disease: history of MI, angina, PCI, CABG Peripheral vascular disease(arterial): history of claudicatio, CVA, TIA, peripheral revascularisation Arterial Hypertension: Bloodpressure >140/90 or under treatment Diabetes mellitus fasting glycemia >120 mg% or under treatment

Minimal Data Base Hemodynamic status on admission: Systolic bloodpressure < or > 100mmHg Heart rate < or > 100 bpm Killip Class 1: no signs of cardiac failure 2: crepitations at the lung bases 3: pulmonary edema 4: cardiogenic shock ECG : anterior - non-anterior - LeftBBB

Minimal Data Base Reperfusion strategy in acute phase: Thrombolysis Primary PCI /CABG = urgent angiography with PCI if needed Facilitated PCI = urgent PCI following lytic therapy (thrombolyis or GP IIb/IIIa antagonists) Rescue PCI = urgent PCI after failure of thrombolytic therapy No reperfusion therapy

Minimal Data Base Time and transport issues Total ischemic time: <2h, 2-4h, 4-8, 8-12, 12-24, >24h time from onset of pain until start of reperfusion therapy (thrombolysis or first balloon inflation) Door-to balloon/needle time: <30min, 30-60, 60-90, 90-120, >120 min, NA time from diagnosis until begin of reperfusion therapy (thrombolysis or first balloon inflation) Transfer from one hospital to another Use of pre-hospital thrombolysis

TIMI risk score (automatically calculated) Circulation: 2000;102:2031

Minimal Data Base Clinical outcome In hospital mortality (up to one month) Elective coronarography (outside the acute phase) Mortality at one month (facultatif)

Background Reperfusion strategy STEMI STEMI registration in Belgium Electronic CRF Analysis and report Practical organisation

Report analysis benchmarking: on-line!! Enrollment graphs: number of included patients per month number of included patients per region (province) number of included patients per hospital (anonymous) Graph: mortality versus TIMI risk-score (see figure) Benchmarking: Belgian data vs region vs centrum

Benchmarking: mortality

Mortality versus TIMI risk score mortality 40 35 30 25 20 15 10 5 0,8 1,6 2,2 4,4 0 7,3 35,9 26,8 23,4 16,1 12,4 0 1 2 3 4 5 6 7 8 >8 TIMI risk score N= 300 - avg mortality: 6%, avg TIMI risk score= 4 INTIME II (n=14114)

Background Reperfusion strategy STEMI STEMI registration in Belgium Electronic CRF Analysis and report Practical organisation

Practical issues Minimal PC requirements Website: https://www.biwacstemi.be Username and password will be mailed to you Website: different items STEMI: e-crf list of included patients of the hospital Reports (graphs, data benchmarking) Documents (e.g. blanco CRF, explanation, guidelines) Contact address of the steering committee members

Try it out and enjoy